GP consortia will take over from the National Institute for Clinical Excellence (NICE) in deciding which drugs the NHS can and cannot use when they take over commissioning in 2013.NICE’s power to ban drugs it deems too expensive versus their overall benefit will be wiped out, although it will still act in an advisory capacity….
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
